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Protoporphyrinogen oxidase (PPOX), the penultimate enzyme in the haem biosynthetic pathway cata-
lysers the six electron oxidation of protoporphyrinogen-IX to protoporphyrin-IX, in the presence of ﬂavin
adenine dinucleotide (FAD) and oxygen. In humans, partial defects in PPOX result in variegate porphyria.
In this study, the FAD binding region in Myxococcus xanthus PPOX was analysed by engineering and
characterising a selection of mutant proteins. Amino acid residues which interact with FAD via their side
chains were selected for study. Mutants were characterised and compared with wild type protein.
Characterisation included FAD quantitation, analysis of FAD spectra and kinetic assay. Results revealed
that Serine 20 mutants could still bind FAD, but polarity in this position is favourable, yet not essential for
the integrity of FAD binding. Study of Glutamate 39 mutants suggest that a negative charge at position 39
is clearly favoured for interaction with the ribose ring of FAD, as all non-conservative replacements could
not bind sufﬁcient FAD. Asparagine 441 appears not to be directly involved in FAD binding but rather in
stabilizing the FAD, and polarity in this position appears important. Tryptophan 408 may play a role in
orientating or stabilizing the bound substrate during catalysis, and a non-polar (or slightly polar) residue
is favoured at this position; however, aromaticity in this position appears not to be critical. Overall this
study sheds further light on how M. xanthus PPOX interacts with FAD.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
PPOX (E.C. 1.3.3.4), the penultimate enzyme in the haem bio-
synthetic pathway catalyses the removal of electrons from proto-
gen to form proto aided by a FAD cofactor [1]. To form proto,
electrons are removed, starting with two electrons moving from
the tetrapyrrole ring of the substrate to reduce the FAD, which in
turn oxidises the ﬁnal electron acceptor (O2) forming H2O2 in the
process. This desaturation step occurs three times resulting in the
removal of a total of six electrons from protogen to form proto and
three H2O2.B.V. This is an open access article u
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issner).PPOX structures from four species have been resolved to date,
including the human structure [2–5]. These structures provide
new insight into the structure–function properties of this enzyme
and suggest that all the electrons in the reaction are lost from a
single point in the tetrapyrrolic macrocycle, based on the lack of
space for the substrate to rotate in the active site [2,3]. The precise
orientation of the substrate in the active site remains unclear as no
structure including the protogen substrate has been resolved to
date, although modelled substrate has been shown. However, the
positioning of the FAD is clear from the resolved structures, which
reveal a tri-lobed protein including a FAD-binding domain of the
p-hydroxybenzoate hydroxylase-type fold; a substrate-binding
domain enclosing a narrow active site cavity beneath the FAD; and
an alpha-helical membrane-binding domain.
Defects in the gene (PPOX) encoding this enzyme result in re-
duced enzyme activity, and may lead to the characteristic accu-
mulation of haem precursors as well as porphyrin(ogen)s asso-
ciated with VP in humans [6]. To date, 170 VP-causing mutations
have been reported in the Human Gene Mutation Database. In
some cases reduced enzyme activity has been attributed to inferiornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mutations have shed light on the binding properties of FAD in
PPOX [7,8]. Based on the published structures and in silica pre-
dictions [9], mutants have been engineered in which various re-
sidues interacting with the cofactor, FAD, were mutated, and their
effect on FAD binding and/or change in orientation reported. We
also considered earlier work by Maneli et al. [10] which demon-
strated that certain residues are critical for FAD binding. Speciﬁ-
cally, characterisation of HPPOX mutants, Gly9Ala and Gly11Ala,
revealed that FAD was unable to bind in these mutants, whereas a
Gly14Ala mutant bound FAD poorly, suggesting that PPOX, like
other enzymes with characteristic FAD-binding regions, has a
sensitive, co-ordinated interaction with FAD.
Thus, in this study we further characterise the FAD binding
region in PPOX by engineering and characterising a selection of
relevant mutants based on the Myxococcus xanthus form of the
enzyme. As the FAD binding region is highly conserved amongst
ﬂavoproteins [11,12], it is likely to interact similarly with FAD in
different species of PPOX, including MxPPOX, as well as non-re-
lated ﬂavoprotein oxidases.2. Materials and methods
Myxoccocus PPOX plasmid was kindly donated by Professor H.
A. Dailey, University of Georgia, Athens, GA, USA. For mutagenesis,
the QuickChange site-directed mutagenesis system from Strata-
gene was used. Direct sequencing was performed by the core DNA
sequencing facility of the University of Stellenbosch, South Africa,
using the ABI-3100 Auomated Genetic Analyser and a Big Dye
version 3.0 kit (Applied Biosystems, Brachberg, USA). The sonicator
(model XL2020) utilised was from Heat Systems, Framington, NY,
USA. TALON metal afﬁnity resin was obtained from Clonetech la-
boratories, Palo Alto, CA, USA. The Hybaid Omnigene thermal cy-
cler was from Teddington, UK. Spectrophotometric measurements
were performed on a Hitachi U-3200 UV/vis spectrophotometer
from Koki Co. Ltd., Tokyo, Japan. Fluorimetric measurements were
performed on a Hitachi 650-10S ﬂuorescence spectrophotometer,
Koki Co. Ltd., Japan.
2.1. Selection of mutants
For selection of relevant amino acid residues (i.e. those with
potential to play a role in the binding of FAD), protein–FAD in-
teraction was analysed in the MxPPOX crystal structure with and
without bound aciﬂuorfen inhibitor (PDB2IVD and PDB2IVE, re-
spectively) using the software packages LigPlot and PyMol. Pub-
lished PPOX structures generally include the well-known herbici-
dal competitive inhibitor aciﬂuorfen in the active site, as natural
substrate (protogen) is unstable. Structures with aciﬂuorfen
therefore assist our understanding of active site interactions.
Conservation of selected residues was assessed by multiple se-
quence alignment using BioEdit. MxPPOX residues Ser-20, Glu-39,
Trp-408 and Asn-441 were mutated.
2.2. Site-directed mutagenesis
Mutants were engineered according to manufacturer's in-
structions. A selection of single colonies was screened by restric-
tion analysis, where possible. The oligonucleotide primers used in
the mutagenesis, and restriction enzymes, are available on request.
Restriction enzyme digests were analysed on a 6% non-denaturing
polyacrylamide gel to identify positive clones. In positive clones
the entire MxPPOX cDNA was sequenced to ensure the correct
insertion of the mutation, as well as the absence of any erroneous
mutations (primers available on request).2.3. Expression and puriﬁcation of wild type and mutant MxPPOX
Wild type MxPPOX with a 6 His tag in a tac promoter-driven
expression plasmid was transformed in our laboratories into
competent JM109 cells. One ml of 30 % glycerol stock of MxPPOX
was inoculated in 1 L Luria broth (LB), containing 100 mg/ml am-
picillin and incubated for 22 h at 30 °C with shaking (225 rpm).
Mutant MxPPOX JM109 cells were expressed under the same
conditions as wild type.
Cells from the overnight culture were harvested by cen-
trifugation (3000g) for 30 min at 4 °C. The pellet was resuspended
in 30 ml sonication buffer (0.02 M Tris/HCl, 0.1 M NaCl, 1% Tween
20, pH 8.0). Cells were then lysed/sonicated at 60 W for 30 s4
with intermittent cooling on ice. The lysate was centrifuged at
105,000g for 40 min at 4 °C. The supernatant was loaded onto a
column (0.930 cm) containing 600 ml TALON resin, pre-equili-
brated in 10 ml sonication buffer. The ﬂow through was collected
at a ﬂow rate of 15 ml/h. The column was washed with at least
10 ml of wash buffer (0.02 M NaH2PO4, 0.1 M NaCl, 0.5 % Tween 20,
10% glycerol, 0.025 M imidazole, pH 6.3) prior to eluting with
elution buffer (0.05 M NaH2PO4, 0.1 M NaCl, 0.5 % Tween 20, 10%
Glycerol, 0.15 M imidazole, pH 7.0). A ﬁnal concentration of 1 mg/
ml PMSF was added throughout the puriﬁcation procedure. Pur-
iﬁcation of the proteins was assessed on 7.5–17.5% gradient SDS-
PAGE. Protein was quantitated using the Bio-Rad protein micro-
assay with BSA as protein standard.
2.4. PPOX assay
PPOX activity was assessed by measuring product (proto) for-
mation spectroﬂuorimetrically as previously described [10]. Assays
were performed at 37 °C and at pH 8.1.
Kinetic constants KM and kcat were extrapolated from sub-
strate–velocity plots using an iterative Gauss Newton curve ﬁtting
procedure.
2.5. Determination of T½
T½s were determined by incubating aliquots of enzyme at a
speciﬁc temperature ranging from 30 to 65 °C for 5 min then
placing on ice immediately. Speciﬁc activity was then determined
(at excess substrate concentration). T½ was calculated graphically
by plotting temperature versus velocity.
2.6. The effect of pH on activity
The effect of pH on activity was determined over the pH range
6–9 using phosphate (pH range 6–7) and Tris/HCl (pH range 7–9)
buffers.
2.7. Spectral analysis
FAD was quantitated by measuring absorption at a wavelength
of 450 nm in a UV/vis absorption spectrophotometer. Absorbance
at 450 nm was expressed as OD450 nm/mg protein/ml as previously
reported [10,13]. To analyse the potential effects of the mutations
on FAD binding, PPOX UV/vis spectra were recorded from 550 nm
to 250 nm.3. Results and discussion
3.1. PPOX protein sequence and structural analysis
Alignment of MxPPOX with 19 prokaryote, HPPOX and NtPPOX
protein sequences, conﬁrmed the consensus sequence of the FAD
Fig. 1. LigPLot representation of the FAD (highlighted in green) binding site in
subunit A of mxPPOX (PDB: 2IVE) [3]. Black¼carbon; blue¼nitrogen; red¼oxygen;
purple¼phosphate; cyan¼water molecule. Polar interactions are shown as dotted
lines and hydrophobic interactions are shown as “eye lashes”.
Table 1
Puriﬁcation yield and activity of wild type and mutant MxPPOXs.
PPOX Yield of PPOX from
1 L of culture (mg)
Speciﬁc activity
(lmol/mg/min)
Percentage of wild
type activity
Wild type 3.45 71.3 100
Ser20Ala 0.47 5.0 7
Ser20Thr 2.67 7.1 10
Glu39Asp 2.02 13.6 19
Glu39Ala 0.33 0 0
Glu39Lys 4.68 0.1 0
Glu39Gln 0.63 0 0
Trp408Leu 1.34 37.2 52
Trp408Tyr 5.80 12.5 18
Asn441Gln 1.90 19.3 27
Asn441Ile 0.30 11.5 16
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not shown). Residues Ser-20 and Glu-39 of MxPPOX are part of
this consensus sequence and are highly conserved. This suggests
the importance of their interaction with FAD. Furthermore, Asn-
441 is another highly conserved residue among the prokaryotic
PPOXs.
A tryptophan residue is normally seen in protein structures of
the FAD superfamily interacting with the hydrophobic ring of the
FAD isoalloxazine ring [14,15]. In mxPPOX, the positioning of Trp-
408 is further away from the isoalloxazine ring, suggesting that in
mxPPOX, Trp-408 could have an alternative role (Fig. 1). Never-
theless, examination of the alignment suggests that an aromatic
ring is favoured in this position.
Protein–ligand interaction in MxPPOX structure revealed that
the three conserved residues (Ser-20, Glu-39 and Asn-441) inter-
act with FAD via their side chains (Fig. 1), hence, they could pos-
sibly be playing a role in the binding and orientation of FAD. The
Ser-20 side chain makes three interactions with the phosphate
group (phosphate group 1) of FAD (the third interaction is only
visible in 3-D view). The Glu-39 side chain has two carbonyl
groups that interact with the hydroxyl group of the ribose ring.
Asn-441 is located in a long loop that twists perfectly to orientate
the Asn-441 residue to interact with the phosphate group 2 of FAD
via its side chain and the amino group with the ribityl chain of theFAD. Due to the fact that side chain interactions allow for more
movement compared to backbone interactions, it is tempting to
speculate that ﬂexibility at both the ribose and phosphate regions
of FAD could be important, beneﬁtting protein–FAD association.
3.2. Expression and mutagenesis
In this study pure, soluble forms of wild-type and relevant
mutant MxPPOXs were required for analysis and characterisation.
A series of ten mutant MxPPOXs were successfully engineered,
expressed, and puriﬁed using metal afﬁnity chromatography at
4 °C. The mutants were chosen based on relevant replacements of
the 4 residues of interest (Ser-20, Glu-39, Asp-441 and Trp-408)
(Table 1). Four mutants had very low expression yields compared
to wild type. IPTG induction had no effect on expression (data not
shown). However, growth at 30 C (rather than at 37 °C) improved
expression and yield was increased by doubling the number of
cells inoculated in 1 L growth media. Growth time was minimised
(18 h) to prevent the production of insoluble inclusion bodies [16].
Speciﬁc activities of the mutants ranged from 0 to 52% of wild-
type activity. Those with zero, or very low activity (Glu39Ala/Lys/
Gln) could not be kinetically characterised further.
3.3. Cofactor and kinetic characterisation
FAD–PPOX interaction was assessed by analysing the binding
properties of FAD in both mutants and wild type MxPPOX (Fig. 2).
Furthermore, the activity and kinetic parameters of the mutant
PPOXs were analysed and compared to wild type (Table 2).
FAD in solution displays typical UV/vis spectra with peaks at
450 nm and 375 nm. Wild type MxPPOX has this typical FAD
spectrum (data not shown). The 450 nm peak is higher than the
375 nm peak indicating an oxidised FAD, and is in keeping with
earlier FAD PPOX studies [10,17].
All mutants bound FAD to varying degrees with the exception
of Glu39Gln and Glu39Ala (Fig. 2).
3.4. Serine 20
The residue Ser-20 was mutated to both an alanine and a
threonine. Surprisingly, Ser20Ala bound FAD (0.7 that of wild
type), even with the removal of the polar side chain. However, a
spectrophotometric scan from 550 to 300 nm showed a shift from
the 375 to 360 nm peak in the case of Ser20Ala (Fig. 3). This al-
teration may be explained by the change in polarity of the residue
or that the integrity of the bound FAD has been altered.
The UV/VIS spectrum of Ser20Thr was similar to that of wild
type and this mutant was also able to bind FAD (to a similar degree
as the Ser20Ala mutant). It is likely that, being a conservative
change, the polar side chain of threonine is able to form polar
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Fig. 2. FAD quantitation in MxPPOX protein; FAD absorbance at 450 nm was expressed as OD450 nm/mg of protein/ml. Data expressed as mean7S.D., n¼3.
Table 2
Kinetic parameters of wild type and mutant MxPPOX proteins. Results expressed as
mean 7 S.D. (n¼3).
n¼3 KM (lM) kcat (s1) kcat/KM (lM1 s1) T½
Wild type 0.3870.03 0.7270.06 1.88 5070.20
Ser20Thr 1.1770.04 0.7870.06 0.67 5070.50
Ser20Ala 0.9270.01 0.4170.02 0.45 5670.70
Glu39Asp 0.5970.03 1.5270.08 2.58 5570.10
Trp408Leu 0.5170.05 0.1470.01 0.28 5270.20
Trp408Tyr 1.4970.09 0.2370.04 0.15 5670.01
Asn441Ile 0.5170.02 0.0870.001 0.16 5670.50
Asn441Gln 0.7570.01 0.3270.01 0.43 5070.50
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wild-type (Fig. 1).
In order to investigate the spectral shift in Ser20Ala, a pH op-
timum analysis was performed on wild type MxPPOX and both
serine mutants. This revealed both wild type and Ser20Thr to have
a pH optimum of 8.1 whilst Ser20Ala, has a lower pH optimum at
7.5. This suggests that the polar group′s interaction with FAD-
phosphate may be important.
Furthermore, Ser20Ala has a T½ of 56 °C conﬁrming that this
mutation has an inﬂuence on the structure–function relationship
of the protein. The increase in T½ could be attributable to the same
properties resulting in the FAD spectral shift.
Ser20Thr had a similar catalytic turnover rate as wild type but a
weaker substrate afﬁnity (increased KM); therefore, the overall
catalytic efﬁciency was decreased compared to wild type (Table 2).
Ser20Ala also had an increased KM compared to wild type, af-
fecting its catalytic efﬁciency but to a greater extent than in the
case of the Ser20Thr. Compromised PPOX function in both mutantsis also reﬂected in the lower speciﬁc activities, with Ser20Thr
being slightly less affected than the Ser20Ala mutant. As a whole,
these results suggest that a polar group may be more favourable at
this position yet not essential.
3.5. Glutamate 39
Glutamate-39 is a polar negative residue that is hydrogen-
bonded to the ribose ring of FAD; this conserved residue is the
only residue interacting with the FAD ribose ring (Fig. 1). Such
interaction (of a glutamate) is conserved in other PPOXs, as well as
other oxidases in the same superfamily. The consensus sequence
suggests that a glutamate or an aspartate is vital in this position.
Indeed a recent publication by Shaub et al., [12] on the FAD-de-
pendent oxidase, phytoene desaturase CRTI from Pantoeaananatis,
noted that the superimposition of the individual domains of six
Rossman fold proteins (including MxPPOX) showed nine residues
making hydrophilic contacts with FAD. Of those nine only Glu39
(Glu31 in CRTI) makes side-chain only contacts with the ribose
moiety, and is one of only six residues that are invariant in all six
proteins.
In this study Glu-39 was mutated to an aspartate, lysine, glu-
tamine and alanine. Glu39Asp bound FAD perfectly well, whereas
Glu39Lys bound to a small extent (0.06 that of wild type) (Fig-
s. 2 and 4). PyMol simulation (data not shown), revealed this
slightly bulky mutant to have inferior interaction with FAD. In the
case of Glu39Gln and Glu39Ala no FAD bound. This implies that
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Fig. 6. UV/VIS spectra (300–530 nm) of wild type, Trp408Tyr and Trp408Leu. En-
zymes (∼10 mM) were recorded in 50 mM NaPO4 buffer pH 7.0, 0.5% Tween 20.
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remaining FAD interactions (such as interaction with the adenine
ring, ribityl chain, isoalloxazine ring) to the extent that it is no
longer able to bind and FAD dissociates readily. This phenomenon
has previously been proposed [17,18].
Interestingly, kinetic analysis of Glu39Asp shows an increase in
both kcat and catalytic efﬁciency (kcat/KM) suggesting an almost
fully functional enzyme. Thus a polar negatively charged residue
clearly is favoured to interact with the FAD ribose ring.
Although the T½ of Glu39Asp revealed an increased T½, this
change, which could be interpreted as indicating structural change
in the active site, did not appear to have any major effect on
substrate afﬁnity. Removal of the negative charge, in mutants
Glu39Gln, Glu39Ala, Glu39Lys resulted in a dramatic reduction in
speciﬁc activity (hence kinetic parameters not determined) again
suggesting the importance of the negative group's interaction with
the ribose ring of FAD.
3.6. Asparagine 441
Asn-441 is positioned to interact via its side chain to possibly
stabilise the ribityl chain of the FAD. A long loop located near the
FAD twists perfectly to orientate the Asn-441 residue to interact
with the phosphate group of the FAD via its side chain. Asn-441
also interacts with the ribityl chain of the FAD via its amino group.
The Asn-441 residue was mutated to an isoleucine and a gluta-
mine residue. Both Asn441Ile and Asn441Gln bound FAD at least
as well as wild type, with similar UV/vis spectra, implying that a
change in polarity in this region does not affect the ability to bind
FAD (Fig. 5). Interestingly, Asn441Gln showed superior FAD bind-
ing to wild type.
PyMol simulation (data not shown) shows that Asn-441 makes
two hydrogen bond interactions with the FAD ribityl group. PyMol
simulation of the mutants revealed that the Asn441Gln mutant
interacts with the phosphate rather than the ribityl chain. PyMol
simulation of Asn441Ile showed that isoleucine was unable to
make a hydrogen bond via its side chain with the ribityl chain of
FAD. Since both mutants were able to bind FAD in the presence of
an altered hydrogen bonding network, it is likely that Asn-441 is
not involved in FAD binding directly but rather in stabilizing and
orientating FAD.
Assessment of the kinetic behaviour revealed that both mu-
tants were less efﬁcient that wild type. The Asn441Ile showed an
11-fold decrease in catalytic efﬁciency compared to wild type as
well as an increase in T½. Asn441Gln, although less efﬁcient than
wild type protein, was more catalytically efﬁcient than the-0.05
0
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Fig. 5. UV/vis spectra (300–550 nm) of wild type, Asn441Gln and Asn441Ile (dot-
ted lines). Enzymes (∼10 mM) were recorded in 50 mM NaPO4 buffer pH 7.0, 0.5%
Tween 20.Asn441Ile mutant. This highlights the importance of a polar side
chain for efﬁciency and interaction with the ribityl chain of FAD.
This conclusion is strengthened by our ﬁnding that Asn-441 is not
involved in binding but rather in the alignment of FAD, as both
mutants bound FAD.
3.7. Tryptophan 408
In MxPPOXs and related oxidases, a tryptophan residue is fre-
quently seen near the isoalloxazine ring of FAD. A tryptophan re-
sidue, near the aromatic non-polar half of the isoalloxazine ring,
has been hypothesised to interact via an aromatic–aromatic in-
teraction to stabilise the bound FAD in other non-related ﬂavo-
protein oxidases [14,15]. In MxPPOX, although Trp-408 aligns with
the tryptophan residues in BsPPOX and NtPPOX, the positioning of
Trp-408 is further away from the isoalloxazine ring, suggesting,
that in MxPPOX Trp-408 could have a different role. In this study
Trp-408 was mutated to a leucine (non-polar linear) and a tyrosine
(polar aromatic). Both mutants bound FAD (0.7 and 1.3 that of
wild type for Trp408Leu and Trp408Tyr, respectively), and had a
similar spectra to wild type MxPPOX (Figs. 2 and 6). Despite the
removal of the aromatic ring, Trp408Leu showed a higher speciﬁc
activity and a better substrate afﬁnity (KM) compared to Trp408Tyr
although both were signiﬁcantly less active and had a lower sub-
strate afﬁnity than wild-type. These effects are reﬂected in their
respective catalytic turnover rates. This is also apparent in the T½
values where Trp408Leu had a slightly increased T½ and Trp408Tyr
more so (Table 2).
These results suggest that a non-polar (or slightly polar) re-
sidue is favoured at this position with regards to activity and
substrate afﬁnity of the enzyme; however, the removal of the
aromatic group resulted in a non-optimally functioning enzyme. In
the strongly polar aromatic replacement (Trp408Tyr) both sub-
strate afﬁnity and enzyme efﬁciency was dramatically reduced
compared to wild-type. Yet, spectral analysis of Trp408Tyr re-
vealed that this polar aromatic is does not appear to affect the
amount of bound FAD adversely (Figs. 2 and 6).4. Conclusions
In this study we investigated the binding, orientation and sta-
bilisation of FAD in MxPPOX by engineering mutants, modelling
highly conserved residues that most likely interact with FAD via
their side chains, and performing functional studies.
We have determined that the Ser-20 mutants studied do not
affect FAD binding signiﬁcantly and that polarity in this position
M.O. Boateng et al. / Biochemistry and Biophysics Reports 4 (2015) 306–311 311may be important for the integrity of FAD binding, yet not es-
sential. By mutating Glu-39 we have also shown that a polar ne-
gatively charged residue clearly is favoured to interact with the
FAD ribose ring. Asn-441 appears not to be involved in the binding
of FAD directly, but in the orientation of the bound FAD and po-
larity in this position appears important for stabilizing the FAD.
Our studies of the Trp408 mutants suggest that aromaticity in this
position is not critical for functionality but that non- or slight-
polarity is important.
This study suggests that the ﬂavin mononuclotide (FMN) and
adenosine diphosphate (ADP) moieties of FAD may play different
roles in the FAD/protein interaction. The ADP which consists of
adenine, ribose and a phosphate group may be involved in the
binding of FAD to the protein. We propose that this region binds
ﬁrst to the protein followed by FMN′s interaction with the protein.
FMN consists of the isoalloxazine ring, ribityl chain and a phos-
phate group. The ribityl group could be aligning the isoalloxazine
ring of the FAD. Isoalloxazine is the reactive part of the FAD, re-
ceiving electrons from substrate, and hence its correct orientation
and alignment is vital in mxPPOX for catalysis.
While this study focuses on characterising PPOX from M. xan-
thus it is possible that these ﬁndings may be extrapolated to the
further understanding of the mechanism of PPOX catalysis, and in
our understanding of PPOX mutant/disease function in variegate
porphyria. It is entirely conceivable that mutations which affect
the binding of FAD result in non-functional protein, leading to the
build-up of porphyrin(ogen)s and potential VP symptomology.Funding
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